Trial In Progress: Phase Ib/Ii Study Of Bcl-2/Bcl-Xl Inhibitor Pelcitoclax (Apg-1252) In Patients With Myelofibrosis (Mf) That Progressed After Initial Therapy
BLOOD(2020)
摘要
Background:
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD(2020)